SEC Company Response from SRx Health Solutions, Inc. (SRXH) (CIK 0001471727) (SRXH) — Jul 9, 2019
SRx Health Solutions, Inc. (SRXH) (CIK 0001471727)
Date: July 9, 2019 · CIK: 0001471727 · Accession: 0001140361-19-012619
AI Filing Summary & Sentiment
File numbers found in text: 333-161943
Referenced dates: June 17, 2019
Show Raw Text
CORRESP
1
filename1.htm
53rd at Third
885 Third Avenue
New York, New York 10022-4834
Tel: +1.212.906.1200 Fax: +1.212.751.4864
www.lw.com
FIRM / AFFILIATE OFFICES
Beijing
Moscow
Boston
Munich
Brussels
New York
Century City
Orange County
Chicago
Paris
Dubai
Riyadh
Düsseldorf
San Diego
Frankfurt
San Francisco
Hamburg
Seoul
Hong Kong
Shanghai
Houston
Silicon Valley
London
Singapore
Los Angeles
Tokyo
Madrid
Washington, D.C.
Milan
July 9, 2019
VIA EDGAR TRANSMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4720
Washington, D.C. 20549
Attention: Joseph Klinko and Lily Dang
Re:
Better Choice Company Inc.
Form 10-K for the Fiscal Year ended August 31, 2018
Filed December 21, 2018
Form 8-K filed May 10, 2019
Form 8-K filed May 23, 2019
File No. 333-161943
Dear Mr. Klinko and Ms. Dang:
On behalf of Better Choice Company Inc., a Delaware corporation (the “Company”), this letter is to confirm the receipt of
your letter dated June 17, 2019 regarding the review of the above-referenced filings (the “Comments”), and to hereby request an extension of the period of time in which the Company has to
respond to the Comments. The Company expects to respond to the Comments on or before July 15, 2019.
If you have any questions or comments with regard to this response or other matters, please call the undersigned at (212) 906-1297.
Very truly yours,
/s/ Erika L. Weinberg
Erika L. Weinberg
of LATHAM & WATKINS LLP
cc:
Damian Dalla-Longa, Co-Chief Executive Officer, Better Choice Company Inc.
Lori Taylor, Co-Chief Executive Officer, Better Choice Company Inc.
Marc D. Jaffe, Esq., Latham & Watkins LLP
Ian D. Schuman, Esq., Latham & Watkins LLP